Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation. Reply

N Engl J Med. 2022 Dec 1;387(22):2100-2101. doi: 10.1056/NEJMc2213437.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Humans
  • Rheumatic Heart Disease* / complications
  • Rheumatic Heart Disease* / drug therapy
  • Rivaroxaban / therapeutic use

Substances

  • Rivaroxaban